Nuvation Bio Inc (NYSE: NUVB): Think Like A Lender, Not An Investor

Nuvation Bio Inc (NYSE:NUVB) currently has a daily average trading volume of 1.62M but it saw 2171262 shares traded in last market. With a market cap of 722.17M USD, the company’s current market price of $2.91 came rising about 3.93 while comparing to the previous closing price of $2.80. In past 52 weeks, the stock remained buoying in the range of price level as high as $4.16 and as low as $0.95.

Taking a look at 20-day trading activity of Nuvation Bio Inc (NUVB) gives us an average price of $3.13, while its current price level is -30.04% below from 52-week high level whereas it is 206.32% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $3.11 while that of 200 days or SMA-200 reads an average of $1.94. A closer look into the stock’s movement over the week reveals that its volatility is standing at 9.59% during that period while stretching the period over a month that decreases to 6.86%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 46.46 which implies that the stock is in neutral territory.

The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the Jefferies which upgraded the stock as “Buy” in its note to investors issued on March 27, 2024, recommending a price target of between $1.40 and $10 for it. BTIG Research upgraded its recommendation for the stock as a “Buy” from “Neutral” on March 26, 2024 while assigning a price target of $5. Jefferies issued its recommendations for the stock as it downgraded the price target for the stock in the range of between $5 and $2.

Over the week, NUVB’s stock price is moving -2.68% down while it is -8.78% when we observe its performance for the past one month. Year-to-date it is 92.72% up and over the past year, the stock is showing an upside performance of 69.19%.

Currently, Nuvation Bio Inc’s total number of outstanding shares is 218.05M. Company’s return on investment (ROI) stands at -11.56% and return on equity (ROE) at -11.15%. Stock’s beta reads 1.41. Stock has a price to book (P/B) ratio of 1.07. Its return on asset (ROA) is -10.84% on average.